Pfizer plans to test Celebrex as heart medication

Pfizer is expected to announce today its plans to back a large-scale clinical trial to test the arthritis drug's ability to prevent heart attacks and strokes in people with serious cardiovascular disease. The trial is seen as a big bet on Celebrex, because if it dampens inflammation and protects the heart, use of Celebrex could increase, while negative results could hurt sales of the $3 billion-a-year drug.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations